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A B S T R A C T
Background: Methicillin-resistant Staphylococcus aureus (MRSA) strains are some of the most widespread
pathogens with multi-resistant to antimicrobial agents (AA). AA provoke several changes inside bacteria,
which cannot be solely explained by the main mechanisms of action reported.
Objective: The role of oxidative stress in bacteria exposed to bacteriostatic AA has not been widely
studied; hence, the aim of our work was to investigate the effect of linezolid (LZD) on S. aureus strains.
Methods: Oxidative stress markers, such as superoxide dismutase (SOD) enzyme activity, the global
antioxidant response, advanced oxidation protein products (AOPP) and basal levels of glutathione in 28
clinical and 2 reference strains were measured.
Results and conclusions: We identified 10 of30 strains showinga slight increase in reactive speciesunderLZD
treatment with respect to the untreated control (between 22% and 56%). Higher generation was detected in
clinical strains compared with the reference strains; however, the impact on the antioxidant response was
not significant, and the oxidized protein levels were almost undetectable. The strains exposed to this
oxazolidinone did not suffer acute oxidative stress. This is the first work reporting the behaviour of clinical
and reference strains of S. aureus exposed to LZD, showing negligible oxidative stress.
© 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial
Chemotherapy. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Methicillin-resistant Staphylococcus aureus (MRSA) strains are
widespread in communities and hospitals around the world. The
ability of pathogens to acquire resistance to available antimicrobial
agents (AA) has therefore become a global problem to be solved [1].
Moreover, in several countries, despite a combination of new AA
and hospital infection control, community strains of MRSA
continue to proliferate [2].
The complex mechanisms related to AA action have been under
increasing scientific study to understand their global effects on
cellular metabolism. Lobritz et al. identified cellular respiration to* Corresponding author.
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http://dx.doi.org/10.1016/j.jgar.2020.02.032
2213-7165/© 2020 The Authors. Published by Elsevier Ltd on behalf of International Societ
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).be a main subprocess after the antibiotic reaches the cellular target
[3]. Numerous studies have also demonstrated that bacterial death
caused by AA cannot be fully ascribed to their interaction with AA
within the reported target. The concomitant occurrence of changes
in cellular metabolism and the induction of reactive oxygen species
(ROS) and reactive nitrogen species (RNS) have been described, and
play a significant role in modulating antibiotic susceptibility [4–9].
Our previous studies have also demonstrated the oxidative damage
provoked under ROS influence, with these species being found to
induce oxidized macromolecules defined as stress markers (e.g.
advanced oxidation protein products, AOPP) in bacteria [10,11].
Moreover, ROS promote the antioxidant defence system to
maintain cell homeostasis, for instance glutathione (GSH) and
superoxide dismutase (SOD) [12]. However, most of these studies
were performed with bactericidal antibiotics.
The oxazolidinone linezolid (LZD) was launched on to the market
in 2000 to treat infections caused by MRSA [13]. It is a bacteriostatic
antibiotic which binds to the 50S subunit of the prokaryotic
ribosome, thereby preventing it from complexing with the 30S
subunit,mRNA, initiationfactorsandformyl methionyl-tRNA [14,15].y for Antimicrobial Chemotherapy. This is an open access article under the CC BY-NC-
258 S.R. Martínez et al. / Journal of Global Antimicrobial Resistance 22 (2020) 257–262LZD is a relatively safe antibiotic when given for short periods;
however, prolonged LZD therapy can cause many side effects.
Vivekanandan et al. reported that LZD showed a significant increase
in lipid peroxidation in MRSA-infected rats and the concomitant
administration of an antioxidant compound reduced LZD-induced
hepatotoxicity and oxidative stress [16]. Wang et al. noted the
oxidative stress generated in blood cells exposed to LZD and linked it
to the resulting haematological toxicity [17,18].
The role of oxidative stress in S. aureus strains under LZD treat-
ment has not been studied. Thus, our central goal was to study if LZD
produces an oxidative and nitrosative stress imbalance by deter-
mining different markers such as ROS levels by reducing nitroblue
tetrazolium (NBT) assay, fluorescence microscopy and spectrofluo-
rometry with specific probes for ROS and RNS; also, the RNS levels
were tested using the Griess method. AOPPs, the enzymatic
antioxidant systems (SOD), the total antioxidant capacity (ferric
reducing antioxidant power [FRAP] assay) and GSH basal levels
were also quantified in 28 geneticallycharacterized S. aureusclinical
isolates and two reference strains, in order to find a relationship
between the mechanism of action of LZD and the oxidative stress.
2. Materials and methods
2.1. Bacterial strains and culture conditions
The reference strains of S. aureus, American Type Culture
Collection (ATCC) 29213 and MRSA ATCC 43300, and 28 genetically
characterized clinical isolates were selected for the present work
(see Supplementary Table S1). The S. aureus clinical strains were
selected from those recovered in different surveillance projects of
molecular epidemiology of MRSA infections in Córdoba, Argentina
during 2001–2014 [19,20]. In addition, the S. aureus strain LGA251-
XI was also analysed. This strain is a livestock-associated MRSA
(LA-MRSA) with SCCmec XI, and was kindly provided by Mark A.
Holmes (Dept. of Veterinary Medicine, University of Cambridge,
UK). The samples were conserved in tryptic soy broth (TSB-
Britania) and glycerol 10% v/v at 80 C. Bacterial strains were
cultured in tryptic soy agar (TSA-Britania) for 18 h at 35 C and
finally, one single isolated colony was collected to culture once
again in the appropriate media depending on the assay conditions.
2.2. Minimum inhibitory concentration determination
The minimum inhibitory concentrations (MICs) were deter-
mined according to the guidelines of the Clinical Laboratories
Standards Institute [21] in all the strains to define the appropriate
antibiotic concentrations in order to perform the oxidative stress
experiments. Overnight cultures obtained in TSA were diluted to
106 CFU/mL in Mueller Hinton broth (Britania). Then, a stock
solution of LZD (Sigma-Aldrich) (10 mL, 32 mg/mL) was prepared in
phosphate-buffered saline (PBS) pH 7, and 500 mL of bacterial
suspensions were inoculated with 500 mL of twofold diluted
solutions of LZD in the concentration range between 16–0.15 mg/
mL. Bacteria growth was observed at 24 h of incubation, according
to Clinical and Laboratory Standards Institute (CLSI) indications.
The MIC was defined as the lowest dilution of drug that inhibited
visible growth (without turbidity) after 24 h of incubation at 35 C.
2.3. Superoxide anion (O2
.-) generation determined by NBT
Overnight cultures of methicillin-sensitive S. aureus (MSSA) ATCC
29213 and MRSA ATCC 43300 in TSB were prepared, after which
each bacterial suspension (OD 1) was centrifuged for 15 min at
4000 rpm and rinsed twice with PBS. Then, 50 mL of bacterial
suspension was incubated with 50 mL of LZD at supra-MIC, MIC and
sub-MIC concentrations for each strain or PBS (control condition)for 4 h followed by addition of 50 mL of NBT (Sigma-Aldrich, 1 mg/
mL) and incubation for 30 min at 35 C in a dark environment. Next,
10 mL of HCl (Cicarelli, 0.1 M) was added, and the samples were
centrifuged at 4000 rpm for 10 min. The pellets were treated with
40 mL dimethyl sulfoxide (DMSO) (Anedra) and finally, the optical
density was assessed at 540 nm [22].
2.4. Reactive nitrogen species measurements
Bacterial suspensions were grown in TSB for 18 h at 35 C (10 mL
of bacterial sample at the following concentration, OD 600 nm 1).
They, were centrifuged for 10 min at 4000 rpm and the pellets were
suspended in PBS. Suspensions of MSSA ATCC 29213 and MRSA
ATCC 43300 (200 mL) were incubated for 4 h with an equal volume
of LZD (4, 2 and 1 mg/mL) or PBS (control without antibiotic), after
which, the samples were centrifuged at 4000 rpm for 10 min,
washed twice with PBS and suspended in PBS. Then, 100 mL of the
supernatants were mixed with 100 mL of Griess reagent (1:1) and
incubated in the dark for 30 min at 35 C. A stock solution of Griess
reagent (Cicarelli), sulfanilamide 2% (w/v) (Sigma-Aldrich) in HCl
(5% v/v) and N-1-naphthyl ethylenediamine dihydrochloride
(Sigma-Aldrich) 0.1% (w/v) in sterile distilled water was prepared.
A standard curve with sodium nitrite in concentrations from 0.8 to
400 mM in PBS was constructed. The spectrophotometry was
performed at 540 nm [23].
2.5. Reactive oxygen species levels by fluorescence microscopy
Suspensions of MSSA ATCC 29213 and MRSA ATCC 43300 in TSB
(10 mL of 1.109 CFU/mL) were centrifuged at 4000 rpm for 10 min
and the pellets were suspended in PBS (5 mL). The suspensions
obtained were incubated with 100 mL of LZD at the MIC of each
strain for 4 h at 35 C or PBS (control without antibiotic) and
centrifuged again at 4000 rpm for 10 min and washed with PBS.
Then, 100 mL of the samples were diluted in 1.8 mL of PBS, and 20
mL of the fluorescent probe 20,70-dichlorodihydrofluorescein
diacetate (DCFH2-DA, Sigma-Aldrich), dissolved in DMSO was
added. The solution was incubated for 30 min in a dark
environment at 35 C. Finally, an aliquot of 20 mL of 40,6-
diamidino-2-phenylindole (DAPI, Sigma-Aldrich) (5 mg/mL in
milliQ water) was poured to stain the DNA as a cell marker.
Fluorescence intensity was measured using a Nikon TE-2000U
microscope (excitation, 490 nm; emission, 519 nm for DCFH2-DA;
and excitation, 358 nm; emission, 461 nm in the case of DAPI
staining) [24].
2.6. Well plate reader measurements: ROS and RNS production
detected with the fluorescent probe dihydrorhodamine 123
The fluorescent probe dihydrorhodamine 123 (DHR; Sigma-
Aldrich) is oxidized to its fluorescent cationic and lipophilic state
upon reaction with ROS and RNS [25]; due to this ability, we
applied this dye for an oxidative and nitrosative stress screening of
the 28 genetically characterized and 2 reference strains of S. aureus
after LZD treatment. Suspensions of MSSA ATCC 29213 and MRSA
ATCC 43300 strains were grown aerobically in TSB (OD 600 nm
1). The inocula (10 mL) were centrifuged for 10 min at 4000 rpm,
and the pellets were rinsed and suspended in PBS. Stock solutions
of 10 mL of LZD were prepared (1–4 mg/mL); 100 mL of bacterial
suspensions were incubated with 100 mL of LZD for 4 h or PBS
(control without antibiotic). Then, 80 mL of PBS plus 20 mL DHR
(final concentration 1 mM, solubilized in 100 mL of DMSO and
diluted in PBS) were added to each well and incubated for 20 min in
dark conditions at 35 C. Fluorescent intensity was recorded using
a Synergy BioTeK multi-mode microplate reader (excitation, 488
nm; emission, 520 nm) [26].
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Overnight cultures (10 mL of bacterial sample at the following
concentration OD 600 nm 1) of four MSSA (MSSA ATCC 29213,
MSSA 15, MSSA 16 and MSSA 22), and four MRSA (MRSA ATCC 43300,
MRSA 5, MRSA 9 and MRSA 28, all strains are described in
Supplementary Table S1) were centrifuged (4000 rpm) for 10 min,
and the pellet was suspended in PBS. In parallel, a stock solution of
LZD was prepared in PBS (80 mg/mL), and 900 mL of bacterial
suspension was mixed with 100 mL of LZD (2 and 4 mg/mL) or PBS
(control without antibiotic) and incubated for different periods (2, 4
and 6 h). Then, 200 mL of each sample treated with LZD was collected
and 10 mL KI (Cicarelli), (1.16 M) and 20 mL of glacial acetic acid were
added. Immediately after the addition of these reagents, the
spectrophotometric reading was performed at 340 nm. AOPP
concentrations were expressed as milliequivalents of chloramine
T per milligram of protein (mEq chloramine T/mg protein) [27].
2.8. Superoxide dismutase activity
Overnight cultures of MRSA and MSSA were obtained in TSB
after overnight culture (10 mL of bacterial sample at the following
concentration OD 600 nm 1). Then, suspensions were centrifuged
for 10 min (4000 rpm) and rinsed with PBS pH 7. An aliquot of 500
mL of bacterial suspension was incubated with an equal volume of
LZD at the concentration of 1, 2 or 4 mg/mL or PBS (control without
antibiotic) for 4 h at 35 C, after which, samples were again
centrifuged for 10 min (4000 rpm). The pellet was solubilized in
250 mL of PBS, and then, 250 mL of DMSO was added to alter the cell
permeability. Finally, the following volumes: 300 mL of methionine
(Sigma-Aldrich) (39 mM); 300 mL of EDTA (300 nM); 100 mL of NBT
(Sigma-Aldrich) (750 mM) and 300 mL of riboflavin (Sigma-
Aldrich) (6 mM) were mixed with 100 mL of the bacterial
suspensions. The samples were exposed to fluorescent light (20
W) for 6 min to trigger the riboflavin reaction. Positive controls
with 30% v/v H2O2 were run in order to define the number of SOD
units corresponding to the percentage reduction of NBT by SOD.
The final absorbance was read at 595 nm [28].
2.9. Ferric reducing ability as a measure of antioxidant power assay
Overnight cultures in TSB (10 mL of 109 CFU/mL) of four MRSA
(MRSA ATCC 43300, MRSA 5, MRSA 9, MRSA 28) and four MSSA
(MSSA ATCC 29213, MSSA 15, MSSA 16, and MSSA 22) were
centrifuged for 10 min at 4000 rpm. The pellets were suspended in
PBS, and LZD solutions (1–4 mg/mL) were prepared in PBS. An
equal volume of the bacterial sample was incubated with LZD
solutions or PBS (control without antibiotic) at 35 C for 4 h. An
aliquot of 10 mL was added to 300 mL of the FRAP reagent mixture,
which was prepared with 10 parts 300 mM acetate buffer (pH 3.6),
one part of 10 mM 2,4,6-Tris(2-pyridyl)-s-triazine (TPTZ, Sigma
Aldrich) solution in 40 mM HCl 1 N, and one part of 20 mM
FeCl3.6H2O (Cicarelli). Aqueous solutions of FeSO4 .7 H2O
(Cicarelli), were used to create a calibration standard curve and
the absorbances were determined in a microplate reader (Bio-Rad)
at 595 nm. Results were expressed as mM FeSO4/mg of protein [29].Fig. 1. Enhancement of intracellular ROS production in MSSA ATCC 29213 shown by the fl
bacteria control. From left to right: MSSA control, blue channel; MSSA control, green chan
(MIC 2 mg/mL, green channel).2.10. Basal levels of glutathione
Overnight suspensions (10 mL of 109 CFU/mL) of four MSSA
(MSSA 29213, MSSA 15, MSSA 16, MSSA 22) and four MRSA strains
(MRSA 43300, MRSA 5, MRSA 9, MRSA 28) were centrifuged (10
min at 4000 rpm) and rinsed with PBS (Basal). Then, 300 mL of 10%
trichloroacetic acid in EDTA was added and neutralized with NaOH
(1 M) to 300 mL of bacterial suspension. The sample was
centrifuged for 10 min at 4000 rpm and incubated with 20 mL
of glutathione reductase (6 U/mL, Sigma), 50 mL of NADPH (4 mg/
mL, Sigma) and 20 mL of 5,5-dithiobis(2-nitrobenzoic acid) (1.5
mg/mL, Sigma) dissolved in 0.5% NaHCO3. The absorbance was
measured at 412 nm, and GSH levels were expressed in mM GSH/
mg of protein [30].
2.11. Data and statistical analysis
All experiments were performed on three independent days.
The results were represented as means of quadruplicates  SD
from the three experiments. One-way ANOVA from OriginPro 8.5
was applied to indicate statistical significance, P < 0.05. The
reactive species induction percentage was calculated relative to







where aut520 is the fluorescence recorded at 520 nm for a specific
strain exposed for 4 h to a specific LZD concentration and auc520 is
the fluorescence outcome at 520 nm from the strain without
treatment.
3. Results
3.1. Minimum inhibitory concentration
The MIC of each strain was determined to determine the
antibiotic concentration to use in the oxidative stress assays. The 2
reference strains (MSSA ATCC 29213 and MRSA ATCC 43300) and
the 28 selected clinical strains for the study were sensitive to LZD,
according to the CLSI breakpoints, with MICs ranging from 1 to 4 m
g/mL (see Supplementary Table S1). The CLSI breakpoints were
considered for interpretation of the MICs (sensitive 4 mg/mL and
resistant 8 mg/mL).
3.2. Screening of reactive oxygen and nitrogen species production
An initial screening of reactive species induction in the reference
strain was carried out. The superoxide anion production obtained
was 18% with respect to the control without antibiotic in MSSA ATCC
29213, treated with 1 mg/mL of LZD and 14% for MRSA ATCC 43300
with 2 mg/mL of LZD (Supplementary Fig. S1), according to the NBT
assay. Additionally, the RNS normalized profile increased twofold
with respect to the control without antibiotic in MSSA ATCC 29213 at
MIC (2 mg/mL) and three-fold with respect to the control for MRSA
ATCC 43300 at 1 mg/mL (Supplementary Fig. S2). To investigateuorescent probe DCFH2-DA (green channel) and DAPI (blue channel) staining as the
nel; MSSA treated with LZD (MIC 2 mg/mL, blue channel) and MSSA treated with LZD
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microscopy was applied with the fluorogenic reporter DCFH2-DA
being sensitive to ROS. Similarly, the enhanced fluorescence
intensity was visualized, which demonstrated the intracellular
productionofROSinMSSA ATCC 29213 by LZD (Fig.1).Thisbehaviour
was different to that registered in MRSA ATCC 43300, which showed
a slight fluorescence (data not shown), indicating that this strain
suffered less stress.
To explore ROS and RNS induction in S. aureus triggered by LZD
treatment, we also tested 28 genetically characterized clinical
strains. The increase in reactive species over time was found for 15
clinical strains and 1 LA-MRSA, with 7 of these showing a
percentage increase of between 22% and 56% with respect to the
control without antibiotic after 4 h of exposure (Supplementary
Fig. S3). Likewise, 3 of the 12 MSSA strains showed higher ROS
production compared with their respective untreated controls
(Supplementary Fig. S4). The fluorescence intensity obtained for
MRSA 5, MRSA 9 and MRSA 28 is shown in Fig. 2. The clinical strains
revealed a stress induction between 44% and 55% higher compared
with the control condition for each (Fig. 2A, inset) and Fig. 2B
(inset) shows the fluorescent intensity in which the strains
presented an increase of between 25% and 35% in MSSA 15, 29
and 31% in MSSA16 and 29% and 35% in MSSA 22. Moreover, it is
noteworthy to mention that LZD induced almost a fourfold ROS
increase in the clinical strains compared with the references
strains, MRSA ATCC 43300 and MSSA ATCC 29213.
To obtain a better understanding of the oxidative behaviour
presented by the strains with the highest reactive species production
(between 22% and 56% higher than the control condition), AOPP,
FRAP, SOD, and GSH determinations were performed.Fig. 2. The fluorescence intensity recorded (proportional to ROS production) as a functio
MRSA strains (MRSA ATCC 43300, grey; MRSA 5, pink; MRSA 9, violet; MRSA 28, red). Inse
22, green). The data represent the mean  SD of four replicates in four independent day
with basal levels (*P  0.05).
Fig. 3. Superoxide dismutase (SOD) activity in S. aureus strains treated with increasing c
bacteria + 2 mg/mL of LZD; and bacteria + 4 mg/mL of LZD. MRSA ATCC 43300, MRSA 5, MR
MSSA strains ATCC 29213, MSSA 15, MSSA 16 and MSSA 22 on the bottom row (from l3.3. Exploring macromolecular damage by advanced oxidation protein
products, a biomarker of oxidative stress
The oxidative stress biomarker AOPP was evaluated to investigate
the damage generatedby ROS and RNS in the stressed strains, and the
oxidative lesion over time was monitored. The AOPP levels showed a
particular pattern in each strain, with results ranging between 200
and 900 mEq chloramine T/mg protein when MSSA and MRSA were
exposed to 2 and 4 mg/mL LZD. However, the increase in the AOPP
levels in each strain after 6 h of incubation with LZD was not
significant compared with the untreated sample (Supplementary
Fig. S5). Meanwhile, the AOPP values has a slight decrease compared
with the initial time (0 h) in MRSA ATCC 43300, MRSA 5, MRSA 9,
MSSA ATCC 29213 and MSSA 22 after 6 h of treatment.
3.4. Superoxide dismutase induction as an acute stress marker
SOD activity was determined to investigate the stress situation
among the strains which showed a reactive species increase. Fig. 3
displays the enzymatic activity of each strain treated with
increasing concentrations of the antibiotic. A slightly dose-
dependent effect was identified for MRSA 5, MRSA 9, MRSA 28
and MSSA ATCC 29213 strains.
3.5. Ferric reducing ability as a measure of antioxidant power assay
After 4 h of exposure with increasing concentrations of LZD, the
FRAP assay was performed in all the strains which showed an
oxidative stress induction above 22% with respect to the control.
No dose-dependent effect was observed and there was a markedn of increasing LZD concentration after 4 h of exposure. Inset A: performance of four
t B: MSSA strains (MSSA ATCC 29213, light grey; MSSA 15, blue; MSSA 16, cyan; MSSA
s. The stressed clinical strains show a statistically significance difference compared
oncentrations of LZD. From left to right: bacteria control; bacteria + 1 mg/mL of LZD;
SA 9 and MRSA 28 are presented on the top row of the plot (from left to right) and the
eft to right).
Fig. 4. Ferric reducing antioxidant power (FRAP) is illustrated in stressed strains
due to LZD treatment. From left to right the bacteria control (in dotted rectangle)
and bacteria with different LZD concentrations are shown (MRSA ATCC 43300, grey;
MRSA 5, pink; MRSA 9, violet; MRSA 28, red; MSSA ATCC 29213, light grey; MSSA 15,
blue; MSSA 16, cyan; MSSA 22, green).
Fig. 5. Basal levels of GSH in MRSA and MSSA strains. The figure shows the quantity
of GSH that each bacterium has available as a non-enzymatic defence system
against oxidative stress before antimicrobial treatment.
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reference strains (MRSA ATCC 43300 and MSSA ATCC 29213) and
six clinical strains (MRSA 5, 9, 28 and MSSA 15,16, 22) where a drop
in reducing ability is highlighted with a dotted line showing the
control condition values which are higher than all treated samples.
The results showed that the total antioxidant capacity was not
exacerbated by treatment with LZD, implying that the cell was not
facing a stress condition.
3.6. Determining the basal levels of a non-enzymatic defence system in
S. aureus strains: glutathione
The levels of intracellular GSH were measured to identify any
potential differences among the MRSA and MSSA strains in order to
confirm the oxidative stress elicited. MRSA 28 and MRSA ATCC
43300 showed the highest GSH basal levels, while the remaining
strains exhibited GSH basal values in the range between 7 and 9 m
M GSH/mg of protein (Fig. 5).
4. Discussion
The present study was designed to investigate the role of
oxidative stress in the mechanism of action of LZD in reference and
clinical strains of S. aureus.
Our results show the effects of LZD exposure on the S. aureus
strains, which displayed diverse stress responses; we detected a
dose-dependent ROS production, such as in the strains MRSA ATCC
43300, MRSA 5, MRSA 27 and MRSA 28 (Supplementary Fig. S3).Other strains showed almost the same levels of reactive species for
the different LZD concentrations: MRSA 1, MRSA 9, MRSA 23, MRSA
24, MSSA 15, MSSA 16, MSSA 22, and MSSA ATCC 29213
(Supplementary Fig. S3 and S4), while the remaining strains
revealed similar values between control and samples treated with
LZD. An interesting result was obtained in the reference strains
treated with LZD, where the RNS increase was significant (P < 0.05).
Previous experiments performed in vitro revealed induced
oxidative stress with bactericidal and bacteriostatic antibiotics
boosting ROS generation in the presence of heavy metal traces (Cu
and Fe). Given this scenario, the oxidative stress observations were
associatedwith the ability to induce Fentonchemistry [31]. Kohanski
et al. demonstrated that bacteriostatic compounds such as
chloramphenicol, tetracycline, erythromycin, and rifampicin did
not induce hydroxyl radical formation as part of their actions.
However, bactericidal compounds promote this formation, resulting
in oxidative damage [32]. ROS disturb the tricarboxylic acid cycle
causing NADH depletion and protein Fe-S cluster destabilization,
thereby releasing Fe2+ and stimulating the Fenton reaction. Other
reports highlight that ROS production depends on the antibiotic and
at which time it was applied against certain microorganisms [33].
Antibioticsaffectseveralsubcellularprocessesconsumingcellular
energy, with relevant consequences on bacterial metabolism. A study
using metabolomics reported that bacteriostatic antibiotics, in
particular, LZD, chloramphenicol, erythromycin and clindamycin in
S. aureus ATCC 25923, can prompt sub-product accumulation from
cellular inhibition. These authors showed that blocking protein
synthesis leads to a decrease in the cellular respiration rates and an
increase in amino acids and nucleotides, displaying a reduced
incorporation of RNA chain and peptides [3]. Other metabolomic
and proteomic signature analyses revealed that the central carbon
metabolism is suppressed due to bacteriostatic treatment [34,35].
Our results for clinical S. aureus strains where ROS production
was observed did not reveal any increase in antioxidant systems to
counterbalance oxidative species to preserve cell homeostasis.
Also, the response of SOD activity, an acute stress marker, was
practically the same as for the control condition.
In terms of AOPP as a consequence of antibiotic exposure, ROS
formation did not stimulate oxidative damage, which showed
similar values over time for the control and the treated strains.
Bactericidal antibiotics increase the metabolic cellular rates,
with the antibiotic efficacy being linked to the metabolic state of
the bacterial sample during treatment [36]. Also, the bactericidal
response affects the upregulation of the genes involved in the
central carbon metabolism and cellular respiration, and several
reports have suggested that antibiotics induce cellular death
according to the oxidative stress levels provoked [37]. Related to
this, it has been postulated that cellular death depends on the
energetic cost required for the cell to turn on the cellular
reparation machinery to deal with the damage [38,39].
In a previous work with a bacteriostatic antibiotic, Albesa et al.
reported a dose-dependent reactive species formation in S. aureus
strains with chloramphenicol, with a slight augmentation in ROS of
1.2 times when they were incubated with the antibiotic compared
with the untreated strains (ROS with antibiotic/ROS without
antibiotic) [40].
Recently, other authors contributed to revealing the role of ROS
in Streptococcus pneumoniae clinical strains, under bactericidal and
bacteriostatic antibiotics, with LZD being one of the studied
antibiotics. They tested 13 clinical isolates under LZD, erythromy-
cin and tetracycline (all 20  MIC) exposure having minimally
raised ROS levels [41].
Our results support the hypothesis that the inhibition of protein
synthesis evokes a deceleration of cellular respiration that is
crucial to metabolic activity. Moreover, our data showed a ROS
induction which could depend on the metabolic situation of each
262 S.R. Martínez et al. / Journal of Global Antimicrobial Resistance 22 (2020) 257–262planktonic strain. The cells which did not exhibit oxidative stress
may be in a dormant state, preventing the occurrence of ROS
induction. The oxidative stress markers and the antioxidant global
capacity did not show a marked increase, implying that the strains
were not under an oxidative stress environment due to LZD
exposure. Summing up, 10 strains (two reference and eight clinical
strains) studied did reveal reactive species formation; however,
this increase was insufficient to lead the cell to a state of acute
oxidative stress. These results are in agreement to previous reports
with bacteriostatic antibiotics [32].
In conclusion, the bacterial stress observed was associated with
the metabolic state of each strain; although it was insufficient to
induce oxidative damage. Thus, the effects mediated by ROS
induction might not have played a significant role in the LZD
inhibitory action compared with bactericidal antibiotics.
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